Fennec Pharmaceuticals Inc. (TSX:FRX)
11.33
0.00 (0.00%)
Jun 4, 2025, 9:30 AM EDT
Fennec Pharmaceuticals Revenue
Fennec Pharmaceuticals had revenue of $8.75M USD in the quarter ending March 31, 2025, a decrease of -65.52%. This brings the company's revenue in the last twelve months to $30.91M, down -31.23% year-over-year. In the year 2024, Fennec Pharmaceuticals had annual revenue of $47.54M with 123.69% growth.
Revenue (ttm)
$30.91M
Revenue Growth
-31.23%
P/S Ratio
6.53
Revenue / Employee
$966.00K
Employees
32
Market Cap
290.00M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
dentalcorp Holdings | 1.58B |
Green Thumb Industries | 1.64B |
Sienna Senior Living | 896.45M |
Extendicare | 1.47B |
Trulieve Cannabis | 1.71B |
WELL Health Technologies | 990.34M |
Cronos Group | 179.08M |
Curaleaf Holdings | 1.89B |
Fennec Pharmaceuticals News
- 1 day ago - Fennec Announces Results of Annual Meeting - GlobeNewsWire
- 23 days ago - Fennec Pharmaceuticals Inc. (FENC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Fennec Pharmaceuticals GAAP EPS of -$0.04 beats by $0.05, revenue of $8.75M beats by $0.57M - Seeking Alpha
- 23 days ago - Earnings Scheduled For May 13, 2025 - Benzinga
- 27 days ago - Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewsWire
- 3 months ago - Fennec Pharmaceuticals Inc. (FENC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Fennec Pharmaceuticals GAAP EPS of -$0.06, revenue of $7.93M - Seeking Alpha
- 3 months ago - Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - GlobeNewsWire